Results 21 to 30 of about 15,817 (237)

Incidence and impact of acute kidney injury on patients with implantable left ventricular assist devices: a Meta-analysis

Renal Failure, 2020
Background We aimed to evaluate the acute kidney injury (AKI) incidence and its associated risk of mortality in patients with implantable left ventricular assist devices (LVAD). Methods A systematic literature search in Ovid MEDLINE, EMBASE, and Cochrane
Charat Thongprayoon, Ploypin Lertjitbanjong, Wisit Cheungpasitporn, Panupong Hansrivijit, Tibor Fülöp, Karthik Kovvuru, Swetha R. Kanduri, Paul W. Davis, Saraschandra Vallabhajosyula, Tarun Bathini, Kanramon Watthanasuntorn, Narut Prasitlumkum, Ronpichai Chokesuwattanaskul, Supawat Ratanapo, Michael A. Mao, Kianoush Kashani   +15 more
doaj   +1 more source

Left ventricular assist device implantation and concomitant aortic valve replacement [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2019
Introduction. The implantable device for mechanical support of the left ventricular circulation (LVAD) is widely applied as a therapeutic option for survival and improvement of the quality of life in patients with the end-stage heart failure.
Mikić Aleksandar, Nestorović Emilija, Bilbija Ilija, Terzić Duško, Putnik Svetozar   +4 more
doaj   +1 more source

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

Transplantation Direct, 2022
Background. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of ...
Thiru Chinnadurai, MD, Snehal R. Patel, MD, Omar Saeed, MD, Waqas Hanif, MD, Mercedes Rivas-Lasarte, MD, PhD, Muhammad Farooq, MD, Carolyne Castillo, BSN, RN, Maria Taveras, BSN, RN, Daphenie Fauvel, FNP-BC, Jooyoung J. Shin, MD, Daniel Sims, MD, Sandhya Murthy, MD, Sasha Vukelic, MD, PhD, Patricia Chavez, MD, Stephen Forest, MD, Daniel Goldstein, MD, Ulrich P. Jorde, MD   +16 more
doaj   +1 more source

A Peek at LVADs Pumping to Recovery

Clinical Medicine Insights: Cardiology, 2022
Left ventricular assist devices (LVADs) have revolutionized the management of patients with advanced heart failure refractory to medical therapy. Current indications of LVADs include Bridge to Transplantation (BTT), Destination Therapy (DT) for long-term use, Bridge to the Decision (BTD) used as a temporary measure, and lastly Bridge to Recovery (BTR).
Samiullah Arshad, Rachel D Cutting, Daniel J Stephens, Ythan H Goldberg, Claudius Mahr, Mahender Vyasabattu, Ahmed H Abdelfattah, Gaurang N Vaidya   +7 more
openaire   +3 more sources

Surgical treatment of the left ventricular assist device drive line infection with abscess formation [PDF]

Scripta Medica, 2018
Specific left ventricular assist device infections are the leading cause of morbidity and second most common cause of death in patients who survive the first six months after implanting device, and also they are the most common cause of readmissions to ...
Terzic Duško, Nestorović Emilija, Putnik Svetozar, Kačar Saša, Jovičić Vladimir, Janjić Ana, Ristić Miljko   +6 more
doaj  

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States

Medicina, 2020
Background: Left ventricular assist device (LVAD) therapy has improved the clinical outcomes in advanced heart failure patients, however, this may differ between countries. We aimed to compare outcomes between Japanese and US LVAD cohorts.
Teruhiko Imamura, Minoru Ono, Koichiro Kinugawa, Norihide Fukushima, Akira Shiose, Yoshiro Matsui, Kenji Yamazaki, Yoshikatsu Saiki, Akihiko Usui, Hiroshi Niinami, Goro Matsumiya, Hirokuni Arai, Yoshiki Sawa, Nir Uriel   +13 more
doaj   +1 more source

Left ventricular assist device implantation as bridge to heart transplantation [PDF]

Scripta Medica, 2017
Heart transplantation is a method of choice for the surgical treatment of a terminal stage of cardiac insufficiency. The lack of donors that all health systems in the world are experiencing has led to the intensive development of devices for permanent ...
Terzić Duško, Putnik Svetozar, Nestorović Emilija, Marković Dejan, Ristić Miljko   +4 more
doaj  

Longitudinal Heart Failure Medication Use and Adherence Following Left Ventricular Assist Device Implantation in Privately Insured Patients

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundThere are few data describing the longitudinal use of and adherence to heart failure medications following left ventricular assist device (LVAD) implantation.
Nicholas Y. Tan, Lindsey R. Sangaralingham, Stephanie R. Schilz, Shannon M. Dunlay   +3 more
doaj   +1 more source

Significance of right ventricular function for the outcome of treatment and remodeling of the heart after left ventricular assist device implantation [PDF]

Medicinski Podmladak, 2022
The efficiency of the device for permanent circulatory support of the left ventricle has been proven through clinical practice with the trend of constant improvement of treatment results along with biotechnological progress and improvement of surgical ...
Terzić Duško, Mikić Aleksandar
doaj  

Characteristics of patients by gender at initiation of LVAD evaluation (Baseline) and by LVAD implantation status at 6 months.

, 2023
Characteristics of patients by gender at initiation of LVAD evaluation (Baseline) and by LVAD implantation status at 6 months.
Jocelyn S. Thompson (5320649), Tracy Makuvire (17283611), Muhammad H. Maqsood (17283608), Colleen K. McIlvennan (5320655), Larry A. Allen (5320652), Joseph M. Kim (17283605), Daniel D. Matlock (5320646), Haider J. Warraich (9212464)   +7 more
core   +1 more source